About the Company
NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. These molecules display pleiotropic activity by virtue of selectively binding to two types of cannabinoid receptors (CB1 and CB2 receptors) located throughout multiple organ systems in the body. NEMUS Bioscience Inc. is developing novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.
NEMUS Bioscience Inc., a Nevada corporation is listed on the OTC Bulletin Board and trading under the symbol NMUS.
Nemus Bioscience Reports Prodrug of Tetrahydrocannabinol (THC) Issued Patent Coverage in Canada and Hong Kong
COSTA MESA, CA–(Marketwired – May 17, 2017) – NEMUS Bioscience, Inc. ( OTCQB : NMUS ) announced that patents have been granted in Canada and Hong Kong covering the company’s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as...
Nemus Bioscience Reports Prodrug of Tetrahydrocannabinol (THC) Receives Second Patent Issued in the United States Related to Proprietary Delivery Mechanisms for Treatment of Glaucoma
COSTA MESA, CA–(Marketwired – May 9, 2017) – NEMUS Bioscience, Inc. ( OTCQB : NMUS ) announced that an additional United States patent has been granted covering the company’s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as other...
COSTA MESA, CA–(Marketwired – May 4, 2017) – NEMUS Bioscience, Inc. ( OTCQB : NMUS ) (the “Company”) today announced the signing of a private placement with an affiliate of Schneider Brothers Ltd, a global closed investment fund with...
NEMUS Bioscience and the University of Mississippi Announce Significant Anti-MRSA Synergy Data Utilizing Proprietary Cannabinoid-Based Anti-Infective Platforms
COSTA MESA, CA–(Marketwired – Mar 22, 2017) – NEMUS Bioscience, Inc. ( OTCQB : NMUS ) and the company’s discovery and research partner, the University of Mississippi (UM), today announced that bactericidal synergy was achieved against multiple species of...